Howard Schwimmer Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 1 day, 20 hours ago
Howard Schwimmer has an estimated net worth of at least $18.5 million*, as of April 22, 2026. They own 328,806 shares of REXR stock. They have sold 114,115 shares of REXR stock since 2021, for an estimated $6.5 million.
Howard Schwimmer $REXR SEC Form 4 Insider Trading
Howard Schwimmer has filed a total of 5 insider trades in $REXR since 2021. Their most recent trade was a sale of 30,358 shares, made on Jul 26, 2024. Their largest trade was a sale of 35,505 shares, made on Apr 28, 2023. We estimate that they now own 328,806 shares of $REXR, worth an estimated $12.0 million.
Insider Trading at $REXR
There have been a total of 21 insider trades reported at $REXR since 2021, with 12,960 shares purchased and 418,114 shares sold. The most active insider traders in $REXR stock have been Michael S. Frankel, David E. Lanzer, and Howard Schwimmer. The most recent trade was a sale of 23,132 shares reported by Michael S. Frankel (Co-CEO, Co-President), made on Mar 17, 2026.
History of Insider Stock Trades by Howard Schwimmer
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
REXR
|
Sale | 30,358 | Jul 26, 2024 | July 26, 2024, 7:12 p.m. |
REXR
|
Sale | 35,505 | Apr 28, 2023 | May 2, 2023, 7:08 p.m. |
REXR
|
Sale | 15,350 | Aug 01, 2022 | Aug. 3, 2022, 8:57 p.m. |
REXR
|
Sale | 16,402 | Jul 25, 2022 | July 26, 2022, 9 p.m. |
REXR
|
Sale | 16,500 | Jun 15, 2022 | June 15, 2022, 9:14 p.m. |
$REXR Executives and Stock Owners with Insider Trades
-
Michael S. Frankel, Co-CEO, Co-President
-
David E. Lanzer, General Counsel & Secretary
-
Howard Schwimmer, Co-CEO, Co-President
-
Laura E Clark, Chief Financial Officer
-
Laura E Clark, Chief Operating Officer
-
Michael Fitzmaurice, Chief Financial Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.